cinacalcet has been researched along with Bone Loss, Osteoclastic in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JF; Chiu, IJ; Hsieh, CY; Hsu, YH; Hung, KC; Hung, LY; Lu, KC; Syu, RS; Wang, TM; Wu, CC; Wu, MS; Wu, MY; Zheng, CM | 1 |
| Chang, TJ; Chiu, HW; Hsu, YH; Lin, YF; Liu, WC; Lu, CL; Lu, KC; Shyu, JF; Wu, CC; Zheng, CM; Zheng, JQ | 1 |
| Barros, X; Torregrosa, JV | 1 |
| Behets, GJ; D'Haese, PC; De Broe, ME; Goodman, WG; Spasovski, G; Spiegel, DM; Sterling, LR | 1 |
| Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Imafuku, A; Kawada, M; Mise, K; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Ubara, Y | 1 |
| Inaba, M | 1 |
| Akizawa, T; Iwasaki, M; Koshikawa, S; Shigematsu, T; Tsukamoto, Y; Uchida, E | 1 |
| Himeno, Y; Shigeno, K; Sugimoto, T; Sumi, M; Suzuki, K; Tokumoto, A; Yano, S | 1 |
| Finch, JL; Lane, N; Nakamura, H; Shahnazari, M; Slatopolsky, E; Tokumoto, M; Yao, W | 1 |
| Goltzman, D | 1 |
| Bajo-Rubio, MA; De Sousa-Amorim, E; Del Peso-Gilsanz, G; Selgas-Gutiérrez, R | 1 |
| Eriguchi, M; Haruyama, N; Kitazono, T; Nakano, T; Tanaka, S; Taniguchi, M; Tsuruya, K; Yamada, S; Yoshida, H | 1 |
1 review(s) available for cinacalcet and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Management of hypercalcemia after renal transplantation.
Topics: Algorithms; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Renal Dialysis; Vitamin D | 2013 |
3 trial(s) available for cinacalcet and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Diseases, Metabolic; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteogenesis; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Young Adult | 2015 |
Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial.
Topics: Aged; Antibodies, Monoclonal, Humanized; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Contraindications; Denosumab; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Osteoclasts; Prospective Studies; RANK Ligand; Renal Dialysis | 2015 |
Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism.
Topics: Adult; Aged; Bone and Bones; Bone Resorption; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Treatment Outcome | 2009 |
8 other study(ies) available for cinacalcet and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Therapeutic Effect of Calcimimetics on Osteoclast-Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone Disease.
Topics: Adult; Aged; Biomarkers; Bone Density; Bone Diseases; Bone Resorption; Calcimimetic Agents; Cinacalcet; Female; Humans; Male; Middle Aged; Osteoblasts; Osteoclasts; Osteogenesis; Outcome Assessment, Health Care; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Tartrate-Resistant Acid Phosphatase | 2020 |
Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease.
Topics: Animals; Bone Density; Bone Resorption; Calcium-Regulating Hormones and Agents; Cells, Cultured; Cinacalcet; Male; Mice; Mice, Inbred C57BL; Osteoclasts; Renal Insufficiency, Chronic; Wnt Proteins | 2019 |
Importance of abnormal bone metabolism in the acceleration of atherosclerosis in hemodialysis patients.
Topics: Atherosclerosis; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Disease Progression; Humans; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |
Bone metabolism after cinacalcet administration in patients with secondary hyperparathyroidism.
Topics: Acid Phosphatase; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Regeneration; Bone Remodeling; Bone Resorption; Calcium; Cinacalcet; Drug Administration Schedule; Female; Hormone Antagonists; Humans; Hyperparathyroidism, Secondary; Isoenzymes; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Tartrate-Resistant Acid Phosphatase; Time Factors | 2010 |
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Topics: Animals; Biomarkers; Bone Resorption; Calcitriol; Calcium; Cinacalcet; Creatinine; Disease Models, Animal; Ergocalciferols; Female; Fibroblast Growth Factors; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Uremia | 2010 |
Do calcimimetics directly alter bone remodeling?
Topics: Animals; Biomarkers; Bone Remodeling; Bone Resorption; Calcitriol; Cinacalcet; Ergocalciferols; Fibroblast Growth Factors; Humans; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Parathyroid Hormone; Rats; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Treatment Outcome; Uremia | 2010 |
Asymptomatic polyostotic Paget's disease associated with secondary hyperparathyroidism in a peritoneal dialysis patient.
Topics: Aged; Alkaline Phosphatase; Arthritis, Gouty; Asymptomatic Diseases; Bone Resorption; Calcifediol; Cinacalcet; Contraindications; Diphosphonates; Humans; Hyperparathyroidism, Secondary; Hypertension; Kidney Failure, Chronic; Male; Naphthalenes; Osteitis Deformans; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Radionuclide Imaging | 2012 |
The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
Topics: Acid Phosphatase; Acute Kidney Injury; Adult; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Resorption; Cinacalcet; Collagen Type I; Cross-Sectional Studies; Female; Humans; Hydroxycholecalciferols; Isoenzymes; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peptides; Peritoneal Dialysis; Raloxifene Hydrochloride; Regression Analysis; Tartrate-Resistant Acid Phosphatase | 2013 |